Man relapsed after treatment for meningitis tied to tainted injections

May 29, 2013 by Steven Reinberg, Healthday Reporter
Man relapsed after treatment for meningitis tied to tainted injections
CDC continues to monitor patients sickened by shots from now-shuttered Mass. pharmacy.

(HealthDay)—Since the start of last year's outbreak of fungal meningitis cases linked to tainted steroid injections, federal health officials have recommended three to six months of antifungal therapy to combat potentially fatal infections.

But health officials reported Wednesday that an 80-year-old man received four-and-a-half months of antifungal therapy and seemed cured, only to suffer a relapse that put him back in the hospital.

Writing in the May 29 online edition of the New England Journal of Medicine, doctors from the U.S. Centers for Disease Control and Prevention said it's not clear if the current treatment guidelines are adequate. "Some patients with infection may require prolonged antifungal therapy owing to the chronic nature of and the difficulty in maintaining adequate drug concentrations" in the , they wrote.

The CDC doctors said they weren't ready to change treatment recommendations at this point. But they continue to monitor clinical reports on the progress of patients treated for tied to the faulty injections that were originally given for back pain.

The infections were caused by a fungus called Exserohilum rostratum, which is basically a common black mold that contaminated vials of steroids produced by the now-shuttered New England Compounding Center in Massachusetts.

Since the first reports back in September, the outbreak has sickened 741 people in 20 states and killed 55.

The CDC report released Wednesday said the 80-year-old man received a contaminated steroid injection on Sept. 12. He arrived at an unnamed hospital on Oct. 4 complaining of a headache and neck pain. A test of his cerebrospinal fluid showed a white cell count of 119 cells per milliliter of fluid.

After being treated with the antifungal medication voriconazole, the man's white cell count had fallen to 5 per milliliter of fluid by Jan. 11. The drug therapy was discontinued Feb. 19, four-and-a-half months after it had started.

But three weeks later, on March 11, the man was back at the hospital emergency department with a headache and neck pain. His white cell count had soared to 2,075 per milliliter of spinal fluid, and he tested positive for E. rostratum.

Therapy with was restarted, and the patient was discharged four days later. When a health department worker visited his home two weeks later, he seemed better, reporting only fatigue, the CDC officials said.

In their letter to the journal, Dr. Rachel M. Smith and colleagues said the agency "is aware of patients who have not had a relapse of disease after three or four months of antifungal treatment, [but] the risk of relapse should be considered when deciding whether to discontinue antifungal therapy. Other factors include the severity of infection, the subsequent response to antifungal treatment, and the side effects of long-term therapy."

The doctors also recommended continued monitoring of patients by health-care experts.

Earlier this month, CDC researchers reported that the tainted steroid injections caused many less-lethal infections, more than half of them in Michigan. As of the first week of May, spinal or near-spinal infections without meningitis had affected 320 people nationwide, with 52 percent of those cases in Michigan.

"Michigan has reported the highest percentage of cases even though we received only 13 percent of the contaminated drug that was shipped nationally," said the report's co-author, Mawuli Nyaku, an epidemic intelligence service officer with the CDC.

The reasons for that disproportionate rate aren't clear, Nyaku said. Nor is it known if more cases will surface.

"We are not out of the woods yet," Nyaku said. "We have never seen anything like this before."

Because the time from injection to symptoms of illness isn't really known, more people who received the tainted drug may develop infections, Nyaku said. "Physicians are seeing patients who have developed infections 200 days after receipt of injection," he said. He urged doctors to consider the possibility of infection in anyone who received the injections.

The infections are localized, concentrated at or near the injection site, and have led to abscesses, pain and some joint infections that necessitated joint replacement, Nyaku explained.

Nyaku said one reason for the high number of cases in Michigan is that St. Joseph Mercy Hospital in Ann Arbor saw the most patients with the infection in the country. To help identify new cases, the hospital offered MRIs to anybody who had been exposed to the contaminated steroids. "In doing so they identified additional cases, which contributed to the high number," Nyaku said.

Another possible explanation, Nyaku said, is that more than 2,000 of the 17,000 vials of tainted drugs were shipped to Michigan. And one of the lots shipped to the state appeared to cause more infections than the other two contaminated lots, he said.

Some patients who stopped therapy also have seen their illness return, he added.

Explore further: Study examines outbreak of spinal infections in Michigan

More information: For more on fungal infections, visit the U.S. Centers for Disease Control and Prevention.

Related Stories

Study examines outbreak of spinal infections in Michigan

May 21, 2013
(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis outbreak, according ...

Fungal meningitis deaths rise to 24, CDC reports

October 25, 2012
The U.S. Centers for Disease Control and Prevention reported Wednesday that a 24th person had died of fungal meningitis after receiving contaminated steroid injections. The latest victim had received an injection to treat ...

FDA warns of infections tied to Tennessee pharmacy

May 24, 2013
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

Meningitis outbreak toll now 23 dead, 297 sickened: CDC

October 22, 2012
(HealthDay)—Twenty-three people have now died and 297 have been sickened in the nationwide meningitis outbreak apparently tied to contaminated steroid injections, U.S. health officials reported Monday.

US : Fungus in tainted steroids and patients match (Update 2)

October 18, 2012
(AP)—The fungus found in tainted steroid shots matches the one blamed in the national meningitis outbreak that has killed 20 people, federal health officials said Thursday.

Steroid-meningitis toll now 32 dead, 438 sickened, CDC says

November 10, 2012
(HealthDay)—Thirty-two people have now died and 438 have been sickened in the fungal meningitis outbreak linked to tainted steroid injections, U.S. health officials reported Friday.

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.